Development of an allele-specific PCR for detection of the K65R resistance mutation in patients infected with subtype C human immunodeficiency virus type 1

Antimicrob Agents Chemother. 2010 Feb;54(2):907-11. doi: 10.1128/AAC.01080-09. Epub 2009 Dec 7.

Abstract

The selection of drug-resistant variants of human immunodeficiency virus type 1 (HIV-1) is an impediment to the efficiency of antiretroviral (ARV) therapy. We have developed an allele-specific real-time PCR assay to explore the presence of K65R minority species among treated HIV-1 subtype B and C infections. Thirty HIV-1 subtype C- and 26 subtype B-infected patients lacking K65R as determined by conventional sequencing methods were studied, and viral minority species were found in four HIV-1 subtype C samples.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes
  • Alleles
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use*
  • Benzoxazines / pharmacology
  • Benzoxazines / therapeutic use
  • Cyclopropanes
  • Dideoxynucleosides / pharmacology
  • Dideoxynucleosides / therapeutic use
  • Drug Resistance, Viral / genetics*
  • HIV Infections / drug therapy*
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • HIV-1 / physiology
  • Humans
  • Lamivudine / pharmacology
  • Lamivudine / therapeutic use
  • Mutation
  • Nevirapine / pharmacology
  • Nevirapine / therapeutic use
  • Polymerase Chain Reaction
  • Zidovudine / pharmacology
  • Zidovudine / therapeutic use

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Dideoxynucleosides
  • Lamivudine
  • Zidovudine
  • Nevirapine
  • HIV Reverse Transcriptase
  • efavirenz
  • abacavir